N Singh1, J Ospel2, A Mayank1, M Marko3, O O Zaidat4, N H Mueller-Kronast5, D S Liebeskind6, M Goyal7,8. 1. From the Departments of Clinical Neurosciences (N.S., A.M., M.G.). 2. Department of Radiology (J.O.), University Hospital of Basel, Basel, Switzerland. 3. Department of Neurology (M.M.), Medical University of Vienna, Vienna, Austria. 4. Neuroscience Institute (O.O.Z.), Mercy Health St. Vincent Medical Center, Toledo, Ohio. 5. Department of Neurology (N.H.M.-K.), Delray Medical Center, Delray Beach, Florida. 6. UCLA Comprehensive Stroke Center (D.S.L.), Los Angeles, California. 7. From the Departments of Clinical Neurosciences (N.S., A.M., M.G.) mgoyal@ucalgary.ca. 8. Diagnostic Imaging (M.G.), Foothills Medical Center, University of Calgary, Calgary, Alberta, Canada.
Abstract
BACKGROUND AND PURPOSE: Few studies assess nonstenotic carotid plaques on CTA, and the causative role of these plaques in stroke is not entirely clear. We used CTA to determine the prevalence of nonstenotic carotid plaques (<50%), plaque features, and their association with ipsilateral strokes in patients with cardioembolic and cryptogenic strokes. MATERIALS AND METHODS: Data were from the Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke (STRATIS) registry, a prospective, nonrandomized registry of patients undergoing thrombectomy with the Solitaire device. The prevalence of nonstenotic carotid plaques ipsilateral and contralateral to the stroke was compared in patients with cryptogenic and cardioembolic strokes. Plaque features were further compared within both subgroups between patients with and without ipsilateral stroke. Adjusted associations among nonstenotic carotid plaque, plaque characteristics, and ipsilateral stroke in both subgroups were determined with logistic regression. RESULTS: Of the 946 patients in the data base, 226 patients with cardioembolic stroke (median age, 72 years) and 141 patients with cryptogenic stroke (median age, 69 years) were included in the analysis. The prevalence of nonstenotic carotid plaque in the cardioembolic and cryptogenic subgroups was 33/226 (14.6%) and 32/141 (22.7%), respectively. Bilateral nonstenotic carotid plaques were seen in 10/226 (4.4%) patients with cardioembolic and 13/141 (9.2%) with cryptogenic strokes. Nonstenotic carotid plaques were significantly associated with ipsilateral strokes in the cardioembolic stroke (adjusted OR = 1.91; 95% CI, 1.15-3.18) and the cryptogenic stroke (adjusted OR = 1.69; 95% CI, 1.05-2.73) groups. Plaque irregularity, hypodensity, and per-millimeter increase in plaque thickness were significantly associated with ipsilateral stroke in the cryptogenic subgroup. CONCLUSIONS: Nonstenotic carotid plaques were significantly associated with ipsilateral stroke in cardioembolic and cryptogenic stroke groups, and there was an association of plaque irregularity and hypodense plaque with ipsilateral stroke in the cryptogenic group, suggesting these plaques could be a potential cause of stroke in these patient subgroups.
BACKGROUND AND PURPOSE: Few studies assess nonstenotic carotid plaques on CTA, and the causative role of these plaques in stroke is not entirely clear. We used CTA to determine the prevalence of nonstenotic carotid plaques (<50%), plaque features, and their association with ipsilateral strokes in patients with cardioembolic and cryptogenic strokes. MATERIALS AND METHODS: Data were from the Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke (STRATIS) registry, a prospective, nonrandomized registry of patients undergoing thrombectomy with the Solitaire device. The prevalence of nonstenotic carotid plaques ipsilateral and contralateral to the stroke was compared in patients with cryptogenic and cardioembolic strokes. Plaque features were further compared within both subgroups between patients with and without ipsilateral stroke. Adjusted associations among nonstenotic carotid plaque, plaque characteristics, and ipsilateral stroke in both subgroups were determined with logistic regression. RESULTS: Of the 946 patients in the data base, 226 patients with cardioembolic stroke (median age, 72 years) and 141 patients with cryptogenic stroke (median age, 69 years) were included in the analysis. The prevalence of nonstenotic carotid plaque in the cardioembolic and cryptogenic subgroups was 33/226 (14.6%) and 32/141 (22.7%), respectively. Bilateral nonstenotic carotid plaques were seen in 10/226 (4.4%) patients with cardioembolic and 13/141 (9.2%) with cryptogenic strokes. Nonstenotic carotid plaques were significantly associated with ipsilateral strokes in the cardioembolic stroke (adjusted OR = 1.91; 95% CI, 1.15-3.18) and the cryptogenic stroke (adjusted OR = 1.69; 95% CI, 1.05-2.73) groups. Plaque irregularity, hypodensity, and per-millimeter increase in plaque thickness were significantly associated with ipsilateral stroke in the cryptogenic subgroup. CONCLUSIONS: Nonstenotic carotid plaques were significantly associated with ipsilateral stroke in cardioembolic and cryptogenic stroke groups, and there was an association of plaque irregularity and hypodense plaque with ipsilateral stroke in the cryptogenic group, suggesting these plaques could be a potential cause of stroke in these patient subgroups.
Authors: Andrew J Zhang; Parth Dhruv; Philip Choi; Caitlin Bakker; Jonathan Koffel; David Anderson; Jae Kim; Bharathi Jagadeesan; Bijoy K Menon; Christopher Streib Journal: Stroke Date: 2018-12 Impact factor: 7.914
Authors: Mayank Goyal; Nishita Singh; Martha Marko; Michael D Hill; Bijoy K Menon; Andrew Demchuk; Shelagh B Coutts; Mohammed A Almekhlafi; Johanna M Ospel Journal: Stroke Date: 2020-03-06 Impact factor: 7.914
Authors: Kars C J Compagne; Ad C G M van Es; Olvert A Berkhemer; Jordi Borst; Yvo B W E M Roos; Robert J van Oostenbrugge; Wim H van Zwam; Charles B L M Majoie; Henk A Marquering; Diederik W J Dippel; Aad van der Lugt; Bart J Emmer Journal: Radiology Date: 2017-10-16 Impact factor: 11.105
Authors: G G Ferguson; M Eliasziw; H W Barr; G P Clagett; R W Barnes; M C Wallace; D W Taylor; R B Haynes; J W Finan; V C Hachinski; H J Barnett Journal: Stroke Date: 1999-09 Impact factor: 7.914
Authors: Johanna M Ospel; Nishita Singh; Martha Marko; Mohammed Almekhlafi; Dar Dowlatshahi; Josep Puig; Andrew Demchuk; Shelagh B Coutts; Michael D Hill; Bijoy K Menon; Mayank Goyal Journal: Stroke Date: 2020-05-07 Impact factor: 7.914
Authors: Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly Journal: Lancet Neurol Date: 2014-04 Impact factor: 44.182